Open Norway: Plasma cell aimed treatment with daratumumab in ME/CFS (ResetME) - Haukeland University Hospital

Utsikt said:
I’ve never run a trial, but I always thought the post-trial analysis would be the easy part. Especially when just looking at outcomes of efficacy. I’m assuming most of the data processing is planned ahead, even though the interpretation might throw some curveballs at you.
Click to expand...
Yeah if the Documentary is anything to go by for Ritux they knew basically 20 mins after unblinding that there was no effect.
 
Sad watch but they are very dedicated. LLPC depletion ftw.


What I think is more interesting is that after the RituxME trial failed P3 they still persisted in believing it was autoimmune or antibody related at least and moved on with another trial years later. Have to give them alot of credit for that. And look where we are now.
 
Last edited:
You must log in or register to reply here.
Back
Top Bottom